Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

SMPDL3B Activators

SMPDL3B activators encompass a diverse class of chemicals designed to modulate the activity of the enzyme sphingomyelin phosphodiesterase acid-like 3B (SMPDL3B). This enzyme is implicated in the metabolism of sphingolipids, a class of lipids known to play a critical role in cell membrane structure and signaling. SMPDL3B is thought to influence not only lipid metabolism but also cell membrane dynamics and potentially, signal transduction pathways related to sphingolipid functions.

Direct activators of SMPDL3B would typically engage with the enzyme to enhance its catalytic action, facilitating the hydrolysis of sphingomyelin to ceramide and phosphocholine. The mechanism of such direct activation could involve binding to the active site of SMPDL3B or to allosteric sites that, upon interaction, induce a conformational change resulting in an increased affinity for substrate or a higher turnover rate. These changes could modulate the SMPDL3B activity, thereby regulating the levels of bioactive sphingolipids within the cell. Indirect activators might work by increasing the expression levels of SMPDL3B, either through upregulating gene transcription or by stabilizing the mRNA to boost protein synthesis. They may also act by preventing the degradation of the enzyme, thus prolonging its presence and function within the cell. Another indirect method of activation might involve the modulation of cellular signaling pathways that control the post-translational modification of SMPDL3B, such as phosphorylation, which can affect the enzyme's activity, stability, and interactions with other cellular components.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sebacic acid

111-20-6sc-215843
sc-215843A
100 g
250 g
$20.00
$35.00
(0)

Sphingosine is a precursor of sphingomyelin and can enhance the activity of SMPDL3B by providing more substrate for its sphingomyelinase activity. This leads to an increase in the production of ceramide, a known modulator of many cellular processes.

Fumonisin B1

116355-83-0sc-201395
sc-201395A
1 mg
5 mg
$200.00
$680.00
18
(1)

Fumonisin B1 is an inhibitor of ceramide synthase. By blocking this pathway, it can enhance the activity of SMPDL3B by increasing the availability of sphingosine, the substrate of SMPDL3B, for conversion to ceramide.

Myriocin (ISP-1)

35891-70-4sc-201397
10 mg
$150.00
8
(2)

Myriocin is an inhibitor of serine palmitoyltransferase, which is involved in the de novo synthesis of ceramide. By inhibiting this pathway, it increases the availability of sphingosine for SMPDL3B, enhancing its activity.

D609

83373-60-8sc-201403
sc-201403A
5 mg
25 mg
$189.00
$575.00
7
(1)

D609 is a potent inhibitor of phosphatidylcholine-specific phospholipase C. Its action leads to the accumulation of phosphatidylcholine, which can be converted to sphingomyelin, the substrate of SMPDL3B, thereby enhancing its activity.

Sphingomyelin

85187-10-6sc-201381
sc-201381A
100 mg
500 mg
$180.00
$560.00
3
(1)

Sphingomyelin is a direct substrate of SMPDL3B. Increasing the availability of sphingomyelin can enhance the enzymatic activity of SMPDL3B leading to the production of ceramide.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein is an inhibitor of tyrosine kinases which can influence the sphingolipid metabolism. By inhibiting these enzymes, it can increase the availability of sphingomyelin, the substrate for SMPDL3B, thereby enhancing its activity.